Moleculin Biotech, Inc.
MBRX
$0.9502
$0.07538.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.69% | 5.23% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.90% | 15.36% | |||
| Operating Income | 6.90% | -15.36% | |||
| Income Before Tax | 82.23% | -145.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 82.23% | -145.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 82.23% | -145.24% | |||
| EBIT | 6.90% | -15.36% | |||
| EBITDA | 6.91% | -15.42% | |||
| EPS Basic | 86.90% | -67.92% | |||
| Normalized Basic EPS | 86.90% | -67.92% | |||
| EPS Diluted | 86.90% | -67.92% | |||
| Normalized Diluted EPS | 86.90% | -67.92% | |||
| Average Basic Shares Outstanding | 35.68% | 46.05% | |||
| Average Diluted Shares Outstanding | 35.68% | 46.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||